## QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how Virtual Twin® controls help.

## Beyond Compliance: What ICH M15 Means for the Future of Drug Development

## How interactive value communication tools strengthen the value proposition in healthcare

## The end of the national launch: why regional pharma market access now determines commercial success

## Strategies for navigating loss of exclusivity (LOE) in pharma

## How to Choose the Right LLM for Medical Writing

## Certainty US 2026 recap: advancing model-informed drug development right from the start

## Why ask your CRO to use Pinnacle 21 Enterprise?

## Everything You Need to Know About CRFs in Clinical Trials

## Best Practices for AI Prompt Engineering in Life Sciences